Evolent Health Announces First Quarter 2022 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- Needham Starts NeoVolta (NEOV) at Buy
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
Evolent Health (EVH) Misses Q1 EPS by 6c, Offers Guidance
May 4, 2022 4:49 PM EDTEvolent Health (NYSE: EVH) reported Q1 EPS of ($0.06), $0.06 worse than the analyst estimate of $0.00. Revenue for the quarter came in at $297 million versus the consensus estimate of $286.77 million.
GUIDANCE:
Evolent Health sees Q2 2022 revenue of $290-305 million, versus the consensus of... More
